These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38521384)

  • 1. rBMA: A robust Bayesian Model Averaging Method for phase II basket trials based on informative mixture priors.
    Wang X; Wei W
    Contemp Clin Trials; 2024 May; 140():107505. PubMed ID: 38521384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
    Chu Y; Yuan Y
    Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variance prior specification for a basket trial design using Bayesian hierarchical modeling.
    Cunanan KM; Iasonos A; Shen R; Gönen M
    Clin Trials; 2019 Apr; 16(2):142-153. PubMed ID: 30526008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulations.
    Asano J; Hirakawa A
    Pharm Stat; 2020 Nov; 19(6):975-1000. PubMed ID: 32779393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian local exchangeability design for phase II basket trials.
    Liu Y; Kane M; Esserman D; Blaha O; Zelterman D; Wei W
    Stat Med; 2022 Sep; 41(22):4367-4384. PubMed ID: 35777367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bayesian basket design for genomic variant-driven phase II trials.
    Simon R; Geyer S; Subramanian J; Roychowdhury S
    Semin Oncol; 2016 Feb; 43(1):13-18. PubMed ID: 26970120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Bayesian hierarchical model to accelerate the development of tissue-agnostic drugs and basket trials.
    Jiang L; Nie L; Yan F; Yuan Y
    Contemp Clin Trials; 2021 Aug; 107():106460. PubMed ID: 34098036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapy.
    Jiang L; Li R; Yan F; Yap TA; Yuan Y
    Contemp Clin Trials; 2021 May; 104():106338. PubMed ID: 33711459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian designs of phase II oncology trials to select maximum effective dose assuming monotonic dose-response relationship.
    Guo B; Li Y
    BMC Med Res Methodol; 2014 Jul; 14():95. PubMed ID: 25074481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian adaptive basket trial design using model averaging.
    Psioda MA; Xu J; Jiang Q; Ke C; Yang Z; Ibrahim JG
    Biostatistics; 2021 Jan; 22(1):19-34. PubMed ID: 31107534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian basket trial design with false-discovery rate control.
    Zabor EC; Kane MJ; Roychoudhury S; Nie L; Hobbs BP
    Clin Trials; 2022 Jun; 19(3):297-306. PubMed ID: 35128970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the efficiency of oncology basket trials using a Bayesian approach.
    Liu R; Liu Z; Ghadessi M; Vonk R
    Contemp Clin Trials; 2017 Dec; 63():67-72. PubMed ID: 28629993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borrowing of information across patient subgroups in a basket trial based on distributional discrepancy.
    Zheng H; Wason JMS
    Biostatistics; 2022 Jan; 23(1):120-135. PubMed ID: 32380518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints.
    Chi X; Yuan Y; Yu Z; Lin R
    Biom J; 2024 Mar; 66(2):e2300122. PubMed ID: 38368277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian methods for the analysis of early-phase oncology basket trials with information borrowing across cancer types.
    Jin J; Riviere MK; Luo X; Dong Y
    Stat Med; 2020 Nov; 39(25):3459-3475. PubMed ID: 32717103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian and frequentist approaches to sequential monitoring for futility in oncology basket trials: A comparison of Simon's two-stage design and Bayesian predictive probability monitoring with information sharing across baskets.
    Kaizer A; Zabor E; Nie L; Hobbs B
    PLoS One; 2022; 17(8):e0272367. PubMed ID: 35917296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian basket trial design with exchangeability monitoring.
    Hobbs BP; Landin R
    Stat Med; 2018 Nov; 37(25):3557-3572. PubMed ID: 29984488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian sample size calculations in phase II clinical trials using a mixture of informative priors.
    Gajewski BJ; Mayo MS
    Stat Med; 2006 Aug; 25(15):2554-66. PubMed ID: 16345057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constrained hierarchical Bayesian model for latent subgroups in basket trials with two classifiers.
    Takeda K; Liu S; Rong A
    Stat Med; 2022 Jan; 41(2):298-309. PubMed ID: 34697822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A win ratio-based framework to combine multiple clinical endpoints in exploratory basket trials.
    Zhang P; Li XN
    J Biopharm Stat; 2024 Mar; 34(2):251-259. PubMed ID: 38252040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.